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conserved co-receptor named Orco (Krieger et al., 2003; Jones et al., 2005; Neuhaus et al., 2005; Benton et al., 2006; Sato et al., 2008; Wicher et al., 2008; Vosshall and Hansson, 2011) .
Several methods have been used to express insect ORs in heterologous systems in order to characterize their ligand specificity and to study their functional properties (Fleischer et al., 2018) . For example, the so-called "empty neuron system" allows the ectopic expression of ORs in subsets of olfactory sensory neurons of the vinegar fly Drosophila melanogaster lacking the endogenous OrX, but with a fully functional Orco (Dobritsa et al., 2003; Kurtovic et al., 2007; Gonzalez et al., 2016) . Moreover, in vitro expression systems allow the heterologous expression of OR proteins in animal cells including -among others -Xenopus oocytes (Nakagawa et al., 2005; Wang et al., 2010; Nakagawa and Touhara, 2013) , insect cells (Kiely et al., 2007; Tsitoura et al., 2010; German et al., 2013) and mammalian cells (e.g. HEK293 and CHO) using vectors for transient expression (Sato et al., 2008; Wicher et al., 2008) or as stable lines (Große-Wilde et al., 2006; Jones et al., 2011; Corcoran et al., 2014) .
Each of these methods offers several advantages, but also bears disadvantages: the "empty neuron system" allows the expression of OR proteins in an environment that is very similar to their native olfactory sensillum. However, the generation of transgenic fly lines and the electrophysiological recording tests can be time consuming and are not suitable for highthroughput screening experiments. Xenopus oocytes have been successfully used for extensive screenings of odors and are compatible with automated platforms, but the costs associated with Xenopus rearing or the purchase of oocytes can be prohibitive for very large screenings. Stable and inducible cell lines, on the other hand, originate from cell clones that successfully integrated in their genome an expression cassette containing a tetracyclinedependent promoter driving the expression of Orco and an odor-binding OrX. Such system represents a sort of "gold standard" as cell variability is strongly reduced, compared to constitute an optimal internal negative control. Moreover, the selection of a monoclonal cell population represents -to date -the most effective approach to deal with the limited functional expression of ORs in the plasma membrane in heterologous systems due to an impaired intracellular trafficking of ORs both in insect (German et al., 2013) and mammalian cells (Halty-deLeon et al., 2016) .
Although a thorough investigation of the bottlenecks in insect OR intracellular trafficking has not been performed yet, their retention within intracellular membranes (German et al., 2013) may be due to the lack of specialized components of the OR release mechanism from the endoplasmic reticulum (ER) and the Golgi apparatus in heterologous systems. Several membrane proteins have been shown to direct their intracellular trafficking through small peptide regions. Among others (Schülein et al., 1998; Ammon et al., 2002) , it has been shown that an N-terminal peptide ( 106 VNKFSL 111 ) from the human HCN1 channel facilitates the exit of HCN1 proteins from the ER (Pan et al., 2015) , and the C-terminal portion of the human Rhodopsin ( 344 QVAPA 348 ) -containing the "VxPx" motif -is sufficient to promote the formation of post-Golgi vesicles and their trafficking to the plasma membrane via microtubule-mediated transport (Tai et al., 1999; Deretic et al., 2005; Mazelova et al., 2009; Lodowski et al., 2013) .
In this work, we investigated whether insect ORs tagged at their N-terminus with the HCN1 and Rhodopsin signal peptides show an enhanced trafficking to the plasma membrane in mammalian cells and reach satisfactory functional expression levels even after transient transfection without clonal selection. Moreover, in order to increase the efficiency of gene cotransfection, we designed a new vector based on a commercially available dual-promoter plasmid for mammalian transient transfection. In this way, we aimed at creating a new fast and inexpensive strategy to reliably express insect ORs in mammalian cells for a broad range of application, including automated and high-throughput imaging systems.
Materials and Methods

Constructs
A human codon-optimized version of D. melanogaster Or47a (hOr47a) tagged at the Nterminus with the peptide "QVAPAGKPIPNPLLGLDSTVNKFSL" coding for the human Rhodopsin 344 QVAPA 348 peptide (minimal Rho tag, abbreviated as "mRho" or "R" tag), a V5 tag (GKPIPNPLLGLDST) and the human HCN1 peptide 106 VNKFSL 111 (minimal ER export tag, abbreviated as "mER" or "E" tag) -this construct is hereafter called mRho.V5.mER.hOr47a, or R.E.hOr47a -was synthesized and subcloned into the pcDNA3.1(-) vector (Cat. Nr. V79520, Invitrogen, Carlsbad, CA) using the XbaI and XhoI restriction sites by Eurofins Genomics GmbH (Ebersberg, Germany). Constructs bearing only the V5 and mER peptides (V5.mER.hOr47a, or abbreviated E.hOr47a) and the V5 tag only (V5.hOr47a, or abbreviated hOr47a) were obtained from the mRho.V5.mER.hOr47a construct via PCR using the Advantage 2 PCR kit (Cat. Nr. 639206, Takara, Kusatsu, Japan) using the E.hOr47a_fwd and hOr47a_fwd forward primers, and the common (E.)hOr47a_rev reverse primer, respectively. A previously described non-human codon optimized version of D. melanogaster Orco cloned in pcDNA3.1(-) (Mukunda et al., 2014) was used for cotransfection of the hOr47a constructs in pcDNA3.1(-).
We created a high-copy number bidirectional expression vector (hence called pCMV-BI) by inserting the bidirectional promoter cassette flanked by the termination regions of the pBI-CMV1 vector (Cat. Nr. 631630 Clontech, Mountain View, CA), in the pCMVTNT (Cat.
Nr. L5620, Promega, Madison, WI) vector backbone. Both regions were amplified using Phusion high-fidelity polymerase (Cat. Nr. M0530, New England Biolabs, Ipswich, MA) with the pBI-CMV1_fwd, pBI-CMV1_rev, and pCMVTNT_fwd, pCMVTNT_rev primer couples, respectively. Fragments were assembled using the NEBuilder HiFi DNA Assembly Master Mix (Cat. Nr. E2621, New England Biolabs).
A human codon-optimized version of D. melanogaster Orco (hOrco) tagged at the Nterminus with a myc tag (5'-GAACAGAAACTGATCTCTGAAGAAGACCTG-3') was synthesized by Eurofins Genomics GmbH and subcloned into the pCMV-BI vector using the BamHI and HindIII restriction sites. A version of hOrco bearing the β-globin/IgG chimeric intron from the pCMVTNT vector within the hOrco sixth transmembrane domain was constructed by Phusion polymerase amplification using the hOrcoExon1_fwd, hOrcoExon1_rev, chimeric_intron_fwd, chimeric_intron_rev, hOrcoExon2_fwd and hOrcoExon2_rev primers. A new vector called pDmelOR was then created by cloning this intron-containing version of hOrco into the pCMV-BI vector, after digestion with BamHI and HindIII, using the NEBuilder HiFi DNA Assembly kit.
The mRho.V5.mER.hOr47a construct was inserted in the pDmelOR vector after linearization with EcoRI, using the BI-R.E.hOr47a_fwd and BI-R.E.hOr47a_rev using the NEBuilder HiFi DNA Assembly Master Mix (pDmelOR-mRho.V5.mER.hOr47a, or pDmelOR-R.E.hOr47a). Moreover, a human codon-optimized versions of D. melanogaster Or56a (hOr56a) was synthesized by Eurofins Genomics GmbH and inserted in the pDmelOR vector after linearization with EcoRI, together with the mRho.V5.mER tag using the following set of primers: hOr56a_fwd, hOr56a_rev, hOr56aTag_fwd, hOr56aTag_rev
(pDmelOR-mRho.V5.mER.hOr56a, or pDmelOR-R.E.hOr56a). enhancer region of the pCMV-BI empty plasmid was sequenced using the pBI-CAG_for and pBI-CAG_rev primers. Sequencing of CMV promoter and termination regions from pCMV-BI and related constructs required a preliminary digestion with restriction enzymes, band isolation and purification after gel electrophoresis and possibly amplification of target sequences due to the presence of two very similar CMV promoter and SV40 polyA regions.
The pCMV-BI empty plasmid was digested with DraIII-HF (Cat. Nr. R3510, New England Biolabs) and NcoI-HF (Cat. Nr. R3193, New England Biolabs). The pDmelOR vector was sequenced after digestion with XhoI and PvuI-HF (Cat. Nr. R3150, New England Biolabs); constructs with inserted Or47a and Or56a genes were cut with XhoI and NaeI (Cat. Nr. R0190, New England Biolabs). If required, the inserted Orco gene was subsequently amplified from the Orco-bearing purified plasmid fragment with the pBI-Orco_for and pBI-Orco_rev primers, and the tuning receptor gene with the pBI-OrX_fwd, pBI-OrX_rev primers using the Advantage 2 PCR kit and the resulting PCR products were sequenced. Primer sequences are listed in the Supplementary Table 1 .
Full sequences for the reported constructs and plasmid availability information are accessible at Addgene (https://www.addgene.org) with the following reference numbers: pcDNA3.1(-)-mRho.V5.mER.hOr47a: #126472; pcDNA3.1(-)-V5.mER.hOr47a: #126473; pcDNA3.1(-)-V5.hOr47a: #126474; pCMV-BI: #126475; pDmelOR: #126476; pDmelOR-mRho.V5.mER.hOr47a: #126478; pDmelOR-mRho.V5.mER.hOr56a: #126479.
Transient expression in mammalian cells
HEK293 cells (DSMZ no. ACC 305) were purchased from the Leibniz Institute DSMZ GmbH (Braunschweig, Germany) and grown in DMEM/F12 1:1 medium (Cat. Nr. 11320, Gibco, Life Technologies, Grand Island, NY, USA) supplied with 10% Fetal Bovine Serum at 37°C and 5% CO 2 . Cell transfection was performed by electroporation with an Amaxa 4D- mixture, supplemented with 10% Fetal Bovine Serum. Zero Ca 2+ DMEM was preferred to standard DMEM in a 1:1 mix with F12, as we previously showed that such low-Ca 2+ culture medium better supports the functional expression of insect ORs in HEK293 cells (Miazzi et al., 2019) . Movies of the imaging recordings were exported as uncompressed TIFF files from the Imaging experiments using an automated platform were performed on a BD Pathway 855 (BD Biosciences) controlled by the AttoVision software (version 1.6/855). Excitation at 340 (for 150 ms) and 380 nm (for 250 ms) was performed using the BD Pathway 855 settings and filters for Fura-2 with a 5 s interval between frames. Stimuli consisted of 20 µl solutions of odor at the desired concentration (see Figure 3 ), or 20 µl of 100 µM VUAA1 in SES. The odor solution was presented at the 10 th frame, while the VUAA1 solution was presented at the 30 th frame. After background subtraction, cells were segmented using the built-in tools of 
Results
Targeting of insect ORs to the plasma membrane
We first tested whether the 344 QVAPA 348 (minimal Rho tag, abbreviated as "mRho" or "R" tag) and the 106 VNKFSL 111 (minimal ER export tag, abbreviated as "mER" or "E" tag) peptides from the human Rhodopsin and the HCN1 channel respectively (Figure 1a ) could improve the intracellular trafficking of hOr47a to the plasma membrane in mammalian cells.
For this purpose, we performed functional imaging experiments on HEK293 cells transiently transfected with the constructs shown in Figure 1b and loaded with the calcium dye Fura-2. We stimulated the hOr47a/Orco heteromers with the Or47a agonist pentyl acetate and the Orco synthetic agonist VUAA1 (Figure 1c ). We quantified the increase in intracellular free calcium with respect to the base level (∆[Ca 2+ ] i (nM)) ( Figure 1d ) and the distribution of Ca 2+ responses (Figure 1e and Supplementary Figure 1 (Figure 1d ).
Moreover, the R.E.hOr47a construct induced significantly higher calcium responses to pentyl acetate than the E.hOr47a construct bearing the mER tag alone (Figure 1d, left panel) . In order to calculate and compare the number of responding cells between the tested treatments, we used the distribution of Ca 2+ responses from HEK293 cells transfected with the empty pcDNA3.1(-) vector to calculate threshold values to classify cells as "responding" or "non responding" to an OR agonist. To do so, we calculated the mean response intensity + 2 × SD (Δ[Ca 2+ ] i , in nM) of the top (most responsive) 0.5 percentile of the cumulative distribution of analyzed control cells (transfected with empty vector) after a pentyl acetate and VUAA1 stimulation. The resulting threshold values were 6.75 nM for pentyl acetate and 6.25 nM for VUAA1 ( Supplementary Figure 1) (Figure 1e and Supplementary Figure 1) . These results show that the mRho and mER tags can significantly improve the functional expression of insect ORs in mammalian cells and that the addition of mRho has a significant positive effect compared to the mER tag alone.
Optimization of OR co-transfection in mammalian cells
To improve the chances of successful co-transfection for a tuning OR and the co-receptor
Orco, we designed a new vector made of the plasmid backbone (including the amp resistance gene and a high-copy number ori) of the pCMVTNT vector and the bidirectional expression cassette of the pBI-CMV1 vector, in order to guide the expression of two genes simultaneously (see Methods). We first inserted a human codon-optimized version of D.
melanogaster Orco (hOrco) tagged at the N-terminus with a myc tag in correspondence of the multiple cloning site 1 of the vector. As the CMV promoter can initiate expression in E. coli (Lewin et al., 2005) (Figure 2d ). Moreover, a significantly higher number of cells responded to pentyl acetate and after transfection with pDmelOR-R.E.hOr47a compared to cells co-transfected with R.E.hOr47a and Orco in pcDNA3.1(-) (Figure 2e ). These results propose the pDmelOR vector as an efficient transfection tool for the expression of insect OR fusion constructs with higher efficacy than standard plasmid co-transfection procedures. 
Optimization of transient transfection for automated imaging platforms
Finally, we took advantage of the high level of functional expression reached combining the increased OR trafficking to the plasma membrane using the mRho and mER tags, together with the optimization of the transfection protocol due to the pDmelOR vector, to validate our method using an automated imaging platform (Figure 3) .
A monoclonal stable cell line guarantees a highly homogeneous level of transgene expression within the cell population, which minimizes variability in functional assays. On the other hand, the expected variability in a population of transiently transfected cells is much higher, due to the variation in plasmid copy number between cells that results in different levels of functional expression of the gene of interest. To control for this phenomenon, we stimulated tested cells with VUAA1 100 s after the presentation of the odor stimulus, in order to use the intensity of the response to this synthetic OR agonist as a proxy of the OrX/Orco functional expression level for each cell. In this way, we could remove from downstream analyses those cells that were not expressing ORs at sufficient levels (see Methods), and we could normalize the odor response for each cell to the intensity of the VUAA1 response, thus minimizing the variability induced by the transient transfection protocol (Figure 3a-c) .
Using this method we built dose-response curves for two D. melanogaster ORs, namely the broadly tuned receptor Or47a and the narrowly tuned Or56a, stimulated with their main agonists, pentyl acetate and geosmin respectively, and in both cases the data could be used to obtain high quality fits (Figure 3d-e ). We then tested whether the tuning properties for the Or47a receptor reported in the DoOR database (Münch and Galizia, 2016) could be replicated in HEK293 cells. To do so, we selected nine odors among the known most potent agonists for Or47a ( Supplementary Figure 2) and assessed their relative potency using our assay (Figure 3f ). Interestingly, when ranked according to their expected potency, compared to the DMSO negative control, the odor agonists did not show a monotonic increasing pattern. Odor properties as solubility in water-based solutions may play a role in explaining such pattern. Moreover in the case of 3-octanol, the odor application significantly affected cell activity independently of Or47a expression, as cells transfected with the negative control plasmid showed a significant reduction in the cell fluorescence base level (Figure 3i ).
However, we further investigated whether odor purity could have influenced our results. To do so, we tested two odors (propyl acetate and 3-methylthio-1-propanol) whose relative potency differed from the expected pattern (compare Figure 3f with Supplementary Figure 2) .
For each odor we tested two aliquots with different chemical grade. Interestingly, while the responses to propyl acetate were not affected by the odor chemical grade (Figure 3g ), the responses to 3-methylthio-1-propanol were significantly affected by this factor, indicating that 3-methylthio-1-propanol might not be an actual agonist of Or47a and the source of OR activation might originate from impurities within the extract (Figure 3h ). protein functional expression (for an overview see Baser and van den Heuvel, 2016), and these tools are amenable to a vast array of downstream applications, from imaging to electrophysiology, that can be performed with automated and high-throughput systems (Mattiazzi Usaj et al., 2016; Obergrussberger et al., 2018) .
Discussion
On such a basis, we decided to implement a fast, inexpensive and versatile method for the expression of insect ORs in HEK293 cells. In order to achieve this result, we here tackled two main problems: the poor surface localization of OR proteins in mammalian cells and the limits imposed by the co-transfection of two genes (Orco and an odor-binding receptor) to obtain functional odor-gated ion channels. First, by using small peptides from the human HCN1 and Rhodopsin that are known to facilitate the release of membrane proteins from the ER and its targeting to the plasma membrane, respectively, we obtained a nearly 20-fold increase in the mean response ( Figure 1d ) and a 10-fold increase in the number of cells responding (Figure 1e and Supplementary Figure 1) to an odor stimulation. Then, by adopting a new high-copy number vector based on a bidirectional expression cassette ( Figure   2 ), we significantly improved the expression efficiency of ORs, showing that three-fourths of cells were stimulated with an overall 100-fold increase in the mean ∆[Ca 2+ ] i in response to an odor stimulation, when compared to a standard co-transfection protocol with ORs lacking the HCN1 and Rhodopsin-derived tags (Figure 1-2 and Supplementary Figure 1 ). Finally, thanks to the high expression level and the possibility to use synthetic Orco agonists as internal stimulus controls to account for inter-cell variability, we showed that such system is amenable to be used with automated platforms (Figure 3) and can be consequently used for high-throughput screenings.
Although we proved the effectiveness of such system for two D. melanogaster ORs with different properties -a broadly tuned receptor as Or47a and the narrowly tuned Or56a - it remains to be shown how generalizable such approach is. Mammalian ORs are affected by similar problems regarding an incorrect intracellular trafficking in heterologous expression systems. Although specific classes of proteins have been shown to support the trafficking of mammalian ORs in native olfactory neurons and in heterologous systems (Saito et al., 2004; Mainland and Matsunami, 2012) , conserved OR residues linked to in silico structural stability were shown to impact their functional expression (Ikegami et al., 2019) ; we cannot exclude that insect ORs are subject to similar structural constraints.
Taken together, our results show that by optimizing the intracellular trafficking and transfection conditions of insect ORs, it is possible via transient transfection to achieve expression levels in HEK293 cells that are comparable to more time and resource-demanding methods as the establishment of mammalian stable cell lines. Hence, we hope that such method can advance the study of insect ORs structure and function even in non-model organisms.
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